U.S. Capital Wealth Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-15
Closed -$1.19K – 641
2022
Q4
$1.19K Buy
+15
New +$1.06K ﹤0.01% 1525

Other funds holding ACLS

U.S. Capital Wealth Advisors's ACLS Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Axcelis (ACLS) in Q1 2023, closing a stake of 15 shares — an estimated $1.19K sold.

U.S. Capital Wealth Advisors first reported a position in ACLS in Q4 2022 and held it in 1 quarter. The position peaked at $1.19K in Q4 2022. 378 funds tracked by Wall St. Rank hold ACLS as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Axcelis position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 15 Axcelis shares in Q1 2023, an estimated $1.19K.
  • U.S. Capital Wealth Advisors first reported a position in Axcelis in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Axcelis position peaked at $1.19K in Q4 2022.
  • 378 funds tracked by Wall St. Rank held Axcelis as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.